Everolimus exhibits anti-tumorigenic activity in obesity-induced ovarian cancer

Everolimus inhibits mTOR kinase activity and its downstream targets by acting on mTORC1 and has anti-tumorigenic activity in ovarian cancer. Clinical and epidemiologic data find that obesity is associated with worse outcomes in ovarian cancer. In addition, obesity leads to hyperactivation of the mTO...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Oncotarget
Main Authors: Guo, Hui, Zhong, Yan, Jackson, Amanda L., Clark, Leslie H., Kilgore, Josh, Zhang, Lu, Han, Jianjun, Sheng, Xiugui, Gilliam, Timothy P., Gehrig, Paola A., Zhou, Chunxiao, Bae, Victoria L.
Format: Artigo
Sprog:Inglês
Udgivet: Impact Journals LLC 2016
Fag:
Research Paper
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4991459/
https://ncbi.nlm.nih.gov/pubmed/26959121
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.7934
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker